These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 34392581)

  • 1. Methylation degree of metalloproteinase inhibitor RECK gene: Links to RECK protein level and hepatocellular carcinoma in chronic HCV infection patients.
    Abo El-Khair SM; Elalfy H; Diasty M; Ebrahim EE; Elsamanoudy AZ
    J Biochem Mol Toxicol; 2021 Oct; 35(10):e22886. PubMed ID: 34392581
    [TBL] [Abstract][Full Text] [Related]  

  • 2. RECK Gene Promoter rs10814325 Polymorphism in Egyptian Patients with Hepatocellular Carcinoma on Top of Chronic Hepatitis C Viral Infection.
    Fakhry AB; Ahmed AI; AbdelAlim MA; Ramadan DI
    Asian Pac J Cancer Prev; 2016; 17(5):2383-8. PubMed ID: 27268601
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Aberrant methylation of promoter region of SPINT2/HAI-2 gene: an epigenetic mechanism in hepatitis C virus-induced hepatocarcinogenesis.
    Ramadan RA; Zaki MA; Awad AM; El-Ghalid LA
    Genet Test Mol Biomarkers; 2015 Jul; 19(7):399-404. PubMed ID: 26030814
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The silencing of RECK gene is associated with promoter hypermethylation and poor survival in hepatocellular carcinoma.
    Zhang C; Ling Y; Zhang C; Xu Y; Gao L; Li R; Zhu J; Fan L; Wei L
    Int J Biol Sci; 2012; 8(4):451-8. PubMed ID: 22419890
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Disease progression from chronic hepatitis C to cirrhosis and hepatocellular carcinoma is associated with increasing DNA promoter methylation.
    Zekri Ael-R; Nassar AA; El-Din El-Rouby MN; Shousha HI; Barakat AB; El-Desouky ED; Zayed NA; Ahmed OS; El-Din Youssef AS; Kaseb AO; Abd El-Aziz AO; Bahnassy AA
    Asian Pac J Cancer Prev; 2014 Jan; 14(11):6721-6. PubMed ID: 24377595
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Study of promoter hypomethylation profiles of RAS oncogenes in hepatocellular carcinoma derived from hepatitis C virus genotype 3a in Pakistani population.
    Maryam M; Idrees M
    J Med Virol; 2018 Sep; 90(9):1516-1523. PubMed ID: 29742286
    [TBL] [Abstract][Full Text] [Related]  

  • 7. RECK gene polymorphisms in hepatitis B-related hepatocellular carcinoma: A case-control study.
    Said EM; Salem AA; Shousha HI; Ahmad ES; Alazzouny MA; Ahmed IA; Elfeky HM; Abdelsalam FM
    Arab J Gastroenterol; 2022 Aug; 23(3):201-205. PubMed ID: 35941073
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association of 32-bp deletion polymorphism and promoter methylation of
    Badawy AA; El-Rabat A; Elshazly TA; Ali SA; Alruwaili AM; Gad DF; Dawoud MG; Elmasry EE; Zaki ME
    Br J Biomed Sci; 2019 Oct; 76(4):195-197. PubMed ID: 31109254
    [No Abstract]   [Full Text] [Related]  

  • 9. A comprehensive genome-wide profiling comparison between HBV and HCV infected hepatocellular carcinoma.
    Sun S; Li Y; Han S; Jia H; Li X; Li X
    BMC Med Genomics; 2019 Oct; 12(1):147. PubMed ID: 31660973
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Downregulation of RECK by promoter methylation correlates with lymph node metastasis in non-small cell lung cancer.
    Chang HC; Cho CY; Hung WC
    Cancer Sci; 2007 Feb; 98(2):169-73. PubMed ID: 17233834
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Promoter hypermethylation of p14 (ARF) , RB, and INK4 gene family in hepatocellular carcinoma with hepatitis B virus infection.
    Zhang JC; Gao B; Yu ZT; Liu XB; Lu J; Xie F; Luo HJ; Li HP
    Tumour Biol; 2014 Mar; 35(3):2795-802. PubMed ID: 24254306
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Methylated cysteine dioxygenase-1 gene promoter in the serum is a potential biomarker for hepatitis B virus-related hepatocellular carcinoma.
    Yang Y; Fan YC; Gao S; Dou CY; Zhang JJ; Sun FK; Wang K
    Tohoku J Exp Med; 2014 Mar; 232(3):187-94. PubMed ID: 24646840
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of hepatitis virus and aging on DNA methylation in human hepatocarcinogenesis.
    Nishida N
    Histol Histopathol; 2010 May; 25(5):647-54. PubMed ID: 20238302
    [TBL] [Abstract][Full Text] [Related]  

  • 14. RASSF1A, RECK genotypes and haplotypes in Egyptian population with Hepatocellular carcinoma.
    Abd-Elfatah G; Gad-Allah AN
    Immunol Lett; 2016 May; 173():36-41. PubMed ID: 26921475
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diagnostic Value of the Hypomethylation of the WISP1 Promoter in Patients with Hepatocellular Carcinoma Associated with Hepatitis B Virus.
    Chen LM; Xiang L; Sun WJ; Zhai YJ; Gao S; Fan YC; Wang K
    Tohoku J Exp Med; 2020 Dec; 252(4):297-307. PubMed ID: 33239483
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of circulating miR-182 and miR-150 as biomarkers for cirrhosis and hepatocellular carcinoma post HCV infection in Egyptian patients.
    Shaheen NMH; Zayed N; Riad NM; Tamim HH; Shahin RMH; Labib DA; ELsheikh SM; Moneim RA; Yosry A; Khalifa RH
    Virus Res; 2018 Aug; 255():77-84. PubMed ID: 30003924
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Epidermal growth factor-containing fibulin-like extracellular matrix protein 1, EFEMP1, a novel tumor-suppressor gene detected in hepatocellular carcinoma using double combination array analysis.
    Nomoto S; Kanda M; Okamura Y; Nishikawa Y; Qiyong L; Fujii T; Sugimoto H; Takeda S; Nakao A
    Ann Surg Oncol; 2010 Mar; 17(3):923-32. PubMed ID: 19898900
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Circulating miRNA-122, miRNA-199a, and miRNA-16 as Biomarkers for Early Detection of Hepatocellular Carcinoma in Egyptian Patients with Chronic Hepatitis C Virus Infection.
    El-Abd NE; Fawzy NA; El-Sheikh SM; Soliman ME
    Mol Diagn Ther; 2015 Aug; 19(4):213-20. PubMed ID: 26133725
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Concordance of DNA methylation pattern in plasma and tumor DNA of Egyptian hepatocellular carcinoma patients.
    Iyer P; Zekri AR; Hung CW; Schiefelbein E; Ismail K; Hablas A; Seifeldin IA; Soliman AS
    Exp Mol Pathol; 2010 Feb; 88(1):107-11. PubMed ID: 19818350
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hepatocellular carcinoma suppressor 1 promoter hypermethylation in serum. A diagnostic and prognostic study in hepatitis B.
    Tian MM; Fan YC; Zhao J; Gao S; Zhao ZH; Chen LY; Wang K
    Clin Res Hepatol Gastroenterol; 2017 Mar; 41(2):171-180. PubMed ID: 28189396
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.